EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma.

Zhou, Yujie; Xiao, Dongdong; Jiang, Xiaobing; Nie, Chuansheng

Zhou, Yujie; Xiao, Dongdong; Jiang, Xiaobing; Nie, Chuansheng.

Afiliación

Zhou Y; Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China.
Xiao D; Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China.
Jiang X; Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China. xiaobingjiang2021@126.com.
Nie C; Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, China. 2017xh0116@hust.edu.cn.

J Transl Med ; 21(1): 28, 2023 01 16.

Article en En | MEDLINE | ID: mdl-36647156

Asunto(s)

Apoptosis; Epirregulina; Glioblastoma; Glioma; Humanos; Antígeno 12E7; Biomarcadores; Glioblastoma/genética; Glioma/genética; Péptidos y Proteínas de Señalización Intercelular; Factor A de Crecimiento Endotelial Vascular

Palabras clave

Bulk RNA-seq analysis; CD99; Cuproptosis; Flow cytometry cell cycle; Immune microenvironment; Immunohistochemistry; Single cell RNA-seq; Transwell assays; VEGFA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Apoptosis / Glioblastoma / Epirregulina / Glioma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google